From design to de-risking to delivery of GMP vectors for clinical trials, we power your innovation on the journey from lab to life
ViroCell Biologics is an innovation-driven CDMO focused exclusively on the design and GMP manufacture of lentiviral and gamma-retro viral vectors to enable novel cell and gene therapies to enter clinical trials.
By leveraging Team ViroCell’s 20+ year track record of manufacturing ~200 vectors, we are driven to accelerate the development of much-needed therapies so that disease can recede and progress can prevail.